×

A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil

  • Author

    A Boshier N Pambakian S A W Shakir

    Andrew Boshier, Naz Pambakian, Saad Shakir

  • Cite

    Int J Clin Pharmacol Ther. 2002 Sep;40(9):422-3

A post-marketing observational study to assess the safety of mibefradil in the community in England

  • Author

    J Riley L V Wilton S A W Shakir

    Jane Riley, Lynda Wilton, Saad Shakir

  • Cite

    Int J Clin Pharmacol Ther. 2002 Jun;40(6):241-8

Results of a postal survey of the reasons for non-response by doctors in a Prescription Event Monitoring study of drug safety

  • Author

    Cheryl Key Deborah Layton Saad A W Shakir

    Cheryl Key, Deborah Layton, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2002 Mar;11(2):143-8

Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill Criteria

  • Author

    Saad A W Shakir Deborah Layton

    Saad Shakir, Deborah Layton

  • Cite

    Drug Saf. 2002;25(6):467-71

Matched controls in a case-control study. Does matching by doctor’s list mean matching by relative deprivation?

  • Author

    Margaret Thorogood Ann Arscott Peter Walls Nicholas R Dunn Ronald D. Mann

    Margaret Thorogood, Ann Arscott, Peter Walls, Nick Dunn, Ronald Mann

  • Cite

    Int J Social Research Methodol. January 2002

Prescription-Event Monitoring

  • Author

    Shakir S

    Saad Shakir

  • Cite

    Pharmacovigilance. January 2002

Drug safety: Foreword

  • Author

    Shakir S

    Saad Shakir

  • Cite

    Drug Saf. January 2002

A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England

  • Author

    Lynda V Wilton Saad A Shakir

    Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2002;25(3):213-23

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England

  • Author

    P N Biswasl L V Wilton G L Pearce S Freemantle S A Shakir

    Pipasha Biswas, Lynda Wilton, Gillian Pearce, Shayne Freemantle, Saad Shakir

  • Cite

    J Psychopharmacol. 2001 Dec;15(4):265-71

Montelukast and improvement of eczema: observations from a prescription event monitoring study in England

  • Author

    P Biswas L V Wilton S A Shakir

    Pipasha Biswas, Lynda Wilton, Saad Shakir

  • Cite

    Int J Clin Pharmacol Ther. 2001 Dec;39(12):529-33

Prescription-event monitoring and reporting of adverse drug reactions

  • Author

    E Heeley J Riley D Layton L V Wilton S A Shakir

    Emma Heeley, Jane Riley, Deborah Layton, Lynda Wilton, Saad Shakir

  • Cite

    Lancet. 2001 Dec 1;358(9296):1872-3

Monitoring safety of over the counter drugs [3] (multiple letters)

  • Author

    D Clark D Layton S A Shakir

    David Clark, Deborah Layton, Saad Shakir

  • Cite

    BMJ. 2001 Sep 29;323(7315):706-7

Monitoring the safety of over the counter drugs

  • Author

    D Clark D Layton S A Shakir

    David Clark, Deborah Layton, Saad Shakir

  • Cite

Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports

  • Author

    D Clark D Layton S A Shakir

    David Clark, Deborah Layton, Saad Shakir

  • Cite

    BMJ. 2001 Sep 29;323(7315):706-7

Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997

  • Author

    P M Craig-McFeely N V Acharya S A Shakir

    Patrick Craig-McFeely, Nayan Acharya, Saad Shakir

  • Cite

    Eur J Clin Pharmacol. 2001 Jul;57(4):313-20

Finasteride and tamsulosin used in benign prostatic hypertrophy: A review of the prescription-event monitoring data

  • Author

    S Shakir G Pearce R D Mann

    Saad Shakir, Gillian Pearce, Ronald Mann

  • Cite

    BJU Int. 2001 Jun;87(9):789-96

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

  • Author

    L V Wilton E L Heeley R M Pickering S A Shakir

    Lynda Wilton, Emma Heeley, Ruth Pickering, Saad Shakir

  • Cite

    J Psychopharmacol. 2001 Jun;15(2):120-6

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

  • Author

    D Layton D W Clark G L Pearce S A Shakir

    Deborah Layton, David Clark, Gillian Pearce, Saad Shakir

  • Cite

    Eur J Clin Pharmacol. 2001 May;57(2):167-76

Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group

  • Author

    A Emerson R M Martin M Tomlin R D Mann

    Angela Emerson, Richard Martin, Mark Tomlin, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):95-103

Cardiovascular events in users of sildenafil: Results from first phase of prescription event monitoring in England

  • Author

    S A Shakir L V Wilton A Boshier D Layton E Heeley

    Saad Shakir, Lynda Wilton, Andrew Boshier, Deborah Layton, Emma Heeley

  • Cite

    BMJ. 2001 Mar 17;322(7287):651-2

The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: Results from the MICA case-control study

  • Author

    N R Dunn A Arscott M Thorogood

    Nick Dunn, Ann Arscott, Margaret Thorogood

  • Cite

    Contraception. 2001 Feb;63(2):65-9

Myocardial infarction and oral contraceptives

  • Author

    A Arscott P Nettelfield

    Ann Arscott, Penny Nettelfield

  • Cite

    Prof Nurse. 2001 Feb;16(5):1117-20

Principles of Pharmacovigilance

  • Author

    Shakir SAW Biswas P

    Saad Shakir, Pipasha Biswas

  • Cite

    Pharm Physician. January 2001

Incompleteness of lamotrigine data (multiple letters)

  • Author

    N V Acharya L V Wilton S A Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2001;24(2):155-6

Incompleteness of lamotrigine data

  • Author

    N V Acharya L V Wilton S A Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2001;24(2):155-6.